Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer

NCT02476539 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2 Positive Breast Cancer

Interventions

DRUG: Hemay022

Sponsor

Tianjin Hemay Pharmaceutical Co., Ltd